TP53 and breast cancer: The results showed that SNORD50A/B knockdown significantly reduced the turnover of p53 proteins in p53wt breast cancer cell line MCF-7, while almost did not affect p53 protein stability in p53mt breast cancer cell line MDA-MB-231 (Fig. 3d).